Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 14.25M | $53.0M | 10.20% | -- | 2026-03-31 |
| Deep Track Capital, LP | 9.35M | $35.0M | 6.69% | -- | 2026-03-31 |
| BlackRock, Inc. | 7.41M | $27.0M | 5.30% | +602.2K | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 6.80M | $25.0M | 4.87% | -- | 2026-03-31 |
| Vivo Capital, LLC | 6.67M | $24.0M | 4.77% | -2.22M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.17M | $19.0M | 3.70% | -- | 2026-03-31 |
| Frazier Life Sciences Management, L.P. | 4.93M | $18.0M | 3.53% | -- | 2026-03-31 |
| Rock Springs Capital Management LP | 4.47M | $16.0M | 3.20% | +18.9K | 2026-03-31 |
| Decheng Capital LLC | 4.04M | $15.0M | 2.89% | -- | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.87M | $14.0M | 2.77% | +500.0K | 2026-03-31 |
